Objective:

To investigate the association of cytokines IL-6 and IL-17 with premature coronary artery disease (pCAD), emphasizing the significance of gender-stratified analysis.

Approach:

Key Findings:

• Elevated levels of IL-6 and IL-17 were found in patients with pCAD compared to controls.
• Cytokine levels correlated with traditional cardiovascular risk factors.
• Gender-specific variations in cytokine levels were observed.

Interpretation:

IL-6 and IL-17 may serve as potential biomarkers for early detection and risk stratification of pCAD, highlighting the importance of inflammation in CAD progression and its implications for clinical practice.

Limitations:

• Single-center study may limit generalizability; further multi-center studies are needed.
• Retrospective design may introduce selection bias, affecting the reliability of findings.
• Causality cannot be established due to cross-sectional nature, necessitating longitudinal studies.

Conclusion:

The study suggests that IL-6 and IL-17 could be valuable biomarkers for early-onset CAD, warranting further investigation for personalized treatment strategies and validation of findings.

Source

Based on findings from:

Potential Role of IL-6 and IL-17 as Biomarkers in Early-Onset Coronary Artery Disease: A Cross-Sectional Analysis

Kexin Yang, Sheng Liu, Chenyang Wang, Siyao Ni, Zhijian Yue, Ludan Bi, Yunxiao Yang, Ming Zhang. Bmc Cardiovascular Disorders, 2026.

https://link.springer.com/article/10.1186/s12872-025-05227-0

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.